Sodium Lowering Vascular Effects Trial
Launched by TULANE UNIVERSITY · May 19, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Sodium Lowering Vascular Effects Trial is studying how reducing dietary sodium (salt) can affect heart and blood vessel health, particularly in people with high blood pressure. The goal is to understand how lowering sodium might help prevent heart-related problems, especially for those already at risk. The trial is currently looking for participants who are 40 years or older and have elevated blood pressure, whether or not they are taking medication for it.
If you decide to join, you’ll be part of a study that explores the effects of dietary changes on your cardiovascular health. However, there are some criteria to keep in mind. For example, you should not have severe kidney problems, a history of heart disease, or be pregnant or breastfeeding. Participants will receive guidance on dietary changes and will be monitored throughout the trial. This study aims to provide valuable insights that could lead to better heart health recommendations in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men or women aged ≥40 years. Individuals \<40 years are at a low risk for clinical and subclinical CVD
- • Elevated BP or hypertension (systolic BP ≥120 mmHg and diastolic BP ≥80 mmHg with or without use of antihypertensive medications)
- Exclusion Criteria:
- • Glomerular filtration rate (eGFR) \<30 or end-stage renal disease (kidney transplant or chronic dialysis)
- • History of cardiovascular disease
- • Shift worker or regularly work at night
- • Cancer requiring chemotherapy or radiation treatment in the previous two years
- • Current pregnancy or breastfeeding or plans to become pregnant during the study
- • Consumption of ≥21 alcoholic drinks/week
- • Current participation in another lifestyle intervention or drug trial
- • Current residence or planned residence that makes it difficult to meet trial requirements
- • Other concerns regarding ability to meet trial requirements (at the discretion of the study coordinator)
About Tulane University
Tulane University, a prestigious institution located in New Orleans, Louisiana, is dedicated to advancing medical research and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Tulane leverages its extensive resources and expertise in various fields, including tropical medicine, infectious diseases, and population health. The university's commitment to ethical research practices and patient-centered approaches ensures that clinical trials conducted under its auspices not only contribute to scientific knowledge but also prioritize the well-being of participants. As a leader in clinical research, Tulane University aims to translate findings into tangible health solutions that benefit local communities and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Orleans, Louisiana, United States
Patients applied
Trial Officials
Katherine T Mills, PhD
Principal Investigator
Tulane University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials